Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences

Cancer Research

Volumn 60, Issue 21, 2000, Pages 6142-6147

  Heidenreich, R ^a   Kappel, A ^a   Breier, G ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; ENHANCER REGION; FIBROSARCOMA; GENE EXPRESSION REGULATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSGENE; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; ENDOTHELIUM, VASCULAR; ENHANCER ELEMENTS (GENETICS); FEMALE; FIBROSARCOMA; GENE EXPRESSION; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSGENES;

EID: 0034326809     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Angiogenesis in cancer, vascular, rheumatoid and other diseases
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
4. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
5. Vascular endothelial growth factor: Molecular and biological aspects
6. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
7. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
8. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tomour growth in vivo
9. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
10. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
11. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
12. Flk-1 as a target for tumor growth inhibition
13. Endothelial cell-specific expression of tumor necrosis factor-α from the KDR or E-selectin promoters following retroviral delivery
14. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
15. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
16. Induction of mammary tumors by expression of polyomavims middle T oncogene: A transgenic mouse model for metastatic disease
17. TNF promotes metastasis by impairing natural killer cell activity
18. Vascular endothelial cell lineage-specific promoter in transgenic mice
19. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
20. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice
21. Expressions of PDGF receptor α, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells
22. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
23. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2
24. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
25. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
26. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
27. Tumor induction of VEGF promoter activity in stromal cells
28. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
29. Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. Regulation of Sp1 binding is associated with cell type-specific expression
30. HRF a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 α and developmentally expressed in blood vessels
31. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α
32. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells
33. c-ets1 Proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans
34. Expression of C ETS1 in early chick embryo mesoderm: Relationship to the hemangioblastic lineage
35. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis
36. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
37. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
38. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-medited gene therapy: Implications for clinical trials